Preclinical Research
Much of the published literature concerns laboratory and animal models rather than controlled human trials.
Research-focused reference for BPC-157 concentration mathematics, BAC-water volume examples, published evidence and current regulatory context.
There is no single universal BAC-water volume for BPC-157. The amount of liquid changes the resulting concentration; it does not change the total quantity represented by the vial.
The table below shows how different liquid volumes change the mathematical concentration of several illustrative vial quantities.
| Vial Quantity | 1 mL | 2 mL | 2.5 mL | 3 mL | 5 mL |
|---|---|---|---|---|---|
| 5 mg | 5 mg/mL | 2.5 mg/mL | 2 mg/mL | 1.67 mg/mL | 1 mg/mL |
| 10 mg | 10 mg/mL | 5 mg/mL | 4 mg/mL | 3.33 mg/mL | 2 mg/mL |
| 20 mg | 20 mg/mL | 10 mg/mL | 8 mg/mL | 6.67 mg/mL | 4 mg/mL |
Enter custom vial quantities and liquid volumes in the BacScience Universal BAC Water Calculator.
No universal volume can be prescribed from the vial quantity alone. For concentration mathematics, a 10 mg quantity with 1 mL corresponds to 10 mg/mL; 2 mL corresponds to 5 mg/mL; 2.5 mL corresponds to 4 mg/mL; 3 mL corresponds to approximately 3.33 mg/mL; and 5 mL corresponds to 2 mg/mL.
These values describe concentration only. They do not establish a human dose or product-specific preparation instruction.
BPC-157 is a synthetic 15-amino-acid peptide investigated across experimental models. Its evidence base remains primarily preclinical, while available human studies are small and uncontrolled.
Much of the published literature concerns laboratory and animal models rather than controlled human trials.
A 2025 intravenous pilot included only two participants, illustrating how limited the current human evidence remains.
BPC-157 is not an FDA-approved therapeutic, and FDA has highlighted substantial gaps in safety information.
Proposed mechanisms have largely been explored in preclinical research, including tissue-repair, vascular and inflammatory pathways. Mechanistic findings from cells or animals cannot by themselves establish clinical efficacy or safety in humans.
Research has explored BPC-157 in gastrointestinal and tissue-related experimental settings. In July 2026, FDA's Pharmacy Compounding Advisory Committee materials evaluated BPC-157-related bulk drug substances in the context of ulcerative colitis; FDA concluded that clinical safety information remained insufficient.
A 2025 pilot study administered intravenous BPC-157 to two adults. The study reported no adverse effects in those two participants, but its extremely small sample cannot establish general safety or efficacy.
| Study | Population | Dose Studied | Route | Frequency | Key Point |
|---|---|---|---|---|---|
| Lee & Burgess, 2025 | 2 adults | 10 mg, then 20 mg | IV infusion | Separate study days | Very small safety pilot; further studies required |
A hypothetical 10 mg quantity divided by 2 mL produces a mathematical concentration of 5 mg/mL. If the same 10 mg quantity is divided by 5 mL, the concentration becomes 2 mg/mL. The total represented quantity remains 10 mg.
The vial quantity does not mathematically increase or decrease merely because the liquid volume changes.
With a fixed vial quantity, a larger liquid volume produces a lower mg/mL concentration.
With a fixed vial quantity, a smaller liquid volume produces a higher mg/mL concentration.
This page therefore does not provide a recommended human dose, treatment protocol or self-administration instructions. Mathematical concentration, a dose used experimentally, an FDA-approved dosage and a community protocol are different concepts and should not be treated as interchangeable.
There is no universal volume that can be recommended from the compound name or vial quantity alone. Different liquid volumes produce different mathematical concentrations.
Concentration in mg/mL equals total vial quantity in mg divided by liquid volume in mL.
Mathematically, 10 mg ÷ 2 mL = 5 mg/mL. This is not a dosing recommendation.
Mathematically, 5 mg ÷ 2 mL = 2.5 mg/mL.
No. In the concentration calculation, it changes mg/mL, not the total quantity represented by the vial.
No. BPC-157 is not an FDA-approved therapeutic.
No clinically established human dose has been identified.
Yes. Use the BacScience Universal BAC Water Calculator for custom mathematical concentration inputs.
Last scientifically reviewed: September 10, 2026
Educational and research information only. This page does not provide medical advice, treatment recommendations or human administration instructions.